跳至主要内容
临床试验/DRKS00013027
DRKS00013027已完成未知

Sensorimotor- and whole-body vibration training have the potential to reduce motor- and sensory symptoms of Chemotherapy-induced peripheral neuropathy – a randomized controlled trial - VICE

Deutsche Sporthochschule Köln, Universität Basel0 个研究点目标入组 40 人开始时间: 2017年11月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • •= 18 years old,
  • •oncological disease,
  • •Chemotherapy-induced peripheral neuropathy = grade 1,
  • •healthy controls have to have the same age (+/- 1 year) and gender

排除标准

  • •- neuropathy of other derivation (Diabetes, HIV etc)
  • •- All Illnesses that prevent physical activity
  • •- Contraindications for whole body vibration (Osteosynthesis, instable osteolysis, acute thrombosis, acute prolaps, implants in lower body, pregnancy, acute wounds, fracture of lower extremity in past 2 years etc
  • •- planed operation
  • •- no signed consent or willingness to allow anonymous data collection
  • •- language restrictions or psychological impairments that prevent the understanding of the written consent and/or instructions given
  • •- uncontrolled cerebral fits
  • •- CNS metastatsis

研究者

发起方
Deutsche Sporthochschule Köln, Universität Basel

相似试验